Jurnal
Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes switched from glinides
Aims/Introduction: The efficacy and safety of sitagliptin, a dipeptidyl peptidase (DPP)- 4 inhibitor, were compared with those of glinides in Japanese patients with type 2 diabetes. Materials and Methods: he participants were 82 patients with type 2 diabetes (glycated hemoglobin [HbA1c] ≥6.0% and
No copy data
No other version available